Scientist Profile

Pankaj Sharma, Ph.D.

Email

pankaj@nccs.res.in

Research Areas

Pathogenesis and Cellular Response

Education

Ph.D. (Parasite immunology) Jawaharlal Nehru University, New Delhi. 2017

M.Sc. (Biotechnology) Himachal Pradesh University, Shimla. 2011

 

Research Experience

Scientist D, January 2025 to present, National Centre for Cell Science (BRIC-NCCS), Pune, India

Postdoctoral Researcher, June 2017 to November 2024, Boston Children’s Hospital, Harvard Medical School, Boston, USA.

Research

Our lab is dedicated to understanding the intricate biology of germinal centers (GCs), which are specialized structures in lymphoid organs essential for refining antibody responses. These microenvironments orchestrate the process of affinity maturation, during which antibodies are fine-tuned to target pathogens with high specificity. Our research aims to investigate the cellular and molecular mechanisms that regulate these processes, with particular emphasis on three key areas:

B cell receptor (BCR) signaling in GC B cells

The positive selection of germinal center B cells relies on the affinity of BCRs to antigens, with optimal BCR signaling and balanced T cell help being crucial for effective antibody affinity maturation and diversity. The delicate balance between BCR signaling and help from follicular T helper cells (Tfh) governs expansion of selected clones in the GCs. To understand these mechanisms, we are investigating the signaling dynamics of B cell receptors (BCRs) and their interaction with co-receptors such as CD19, CD21, and CD22 in positively selected GC B cells. A major goal of this research is to examine the spatial organization of these receptors on the cell membrane and how their reorganization, mediated by glycan remodeling through Tfh cell help, facilitates positive selection.

Antibody durability and diversity

A major challenge in vaccine development is the gradual waning of immunity over time, a process that remains poorly understood. While recall responses typically enhance the durability and diversity of immune protection, some viral infections or repeated vaccinations can hinder the formation of secondary germinal centers (GCs), often due to memory from prior antigen exposures. Our lab focuses on unraveling the pathways driving memory and plasma cell differentiation within GCs and understanding the factors that determine this dichotomy. Utilizing GC-specific fate-mapping mouse models, we aim to trace the migration, maintenance, and reentry of differentiated memory B cells in GCs. Additionally, we seek to define the reentry thresholds of memory B cells during secondary responses and investigate how these cells influence overall antibody diversity.

IgG1 memory B cells (MBCs) as reservoir in allergies

Our lab is also investigating the role of IgG1 MBCs in allergic responses. Although allergic reactions are primarily driven by IgE antibodies, IgE-producing plasma and MBCs are short-lived. Instead, long-term allergic memory is maintained by IgG1 MBCs, which act as reservoirs capable of rapidly undergoing class-switch recombination to produce IgE upon allergen exposure. We aim to uncover the mechanisms that sustain IgG1 memory and facilitate the class-switching process to IgE. Additionally, we are investigating whether IgG1 memory established early in life contributes to the progression of inflammatory conditions later in life, often referred to as the "allergic march”.

By understanding the molecular underpinnings of GC biology, we aim to identify novel strategies for enhancing vaccine efficacy against pathogens. Additionally, our work seeks to provide a deeper understanding of the pathological mechanisms that drive autoimmunity and allergies, potentially offering new therapeutic targets for managing these conditions.


 

Publications and patents

Selected Publication

1. Sharma, P., Zhang, X., Ly, K., Qi Wan, Kim, JK., Kain, L., Théry, C., Teyton, L., and Winau, F. (2024). Hyperglycosylation of prosaposin in tumor dendritic cells drives immune escape. Science. 383 (6679): (190-200). DOI: 10.1126/science.adg1955.
2. Sharma, P., Zhang, X., Ly, K., Zhang, Y., Hu, Y., Ye, AY., Hu, J., Kim, JK., Wang, C., Celuzza, Q., Bundle, DR., Furukawa, K., Alt, FW., and Winau, F. (2024). The lipid globotriaosylceramide promotes germinal center B cell responses and anti-viral immunity. Science. 16;383(6684):eadg0564. DOI: 10.1126/science.adg0564.
3. Zhang, X., Sharma, P*., Maschmeyer, P., Hu, Y., Lou, M., Kim, J., Fujii, H., Unutmaz, D., Schwabe, RF., and Winau, F. (2023). GARP on activated hepatic stellate cell is a therapeutic target for liver fibrosis. Journal of Hepatology. 79(5):1214-1225. DOI: 10.1016/j.jhep.2023.05.043. (*shared first author).
4. Sharma, P., Sharma, A., Ganga, L., Satoeya, N., Jha, R., and Srivastava, M. (2021). Acidic Calcium-Independent Phospholipase A2 Regulates Eosinophil-Mediated Pathology during Filarial Manifestation of Tropical Pulmonary Eosinophilia. Journal of Immunology. 206, 722-736. DOI: 10.4049/jimmunol.2000604.
5. Yadav, S., Sharma, P*., Sharma, A., Ganga, L., Saxena, J.K., and Srivastava, M. (2021). Immunization with Brugia malayi Calreticulin Protein Generates Robust Antiparasitic Immunity and Offers Protection during Experimental Lymphatic Filariasis. ACS Infectious Diseases. 7, 790-799. DOI: 10.1021/acsinfecdis.0c00565. (*shared first author).
6. Sharma, P., Levy, O., and Dowling, D.J. (2020). The TLR5 Agonist Flagellin Shapes Phenotypical and Functional Activation of Lung Mucosal Antigen Presenting Cells in Neonatal Mice. Frontiers in Immunology. 11, 171. DOI: 10.3389/fimmu.2020.00171.
7. Sharma, P., Sharma, A., and Srivastava, M. (2017b). In vivo neutralization of alpha4 and beta7 integrins inhibits eosinophil trafficking and prevents lung injury during tropical pulmonary eosinophilia in mice. European Journal of Immunology. 47, 1501-1512. DOI: 10.1002/eji.201747086.
8. Sharma, P., Sharma, A., Vishwakarma, A.L., Agnihotri, P.K., Sharma, S., and Srivastava, M. (2016). Host lung immunity is severely compromised during tropical pulmonary eosinophilia: role of lung eosinophils and macrophages. Journal of Leukocyte Biology. 99, 619-628. DOI: 10.1189/jlb.4A0715-309RR.
9. Sharma, A., Sharma, P., Ganga, L., Satoeya, N., Mishra, S., Vishwakarma, A.L., and Srivastava, M. (2018). Infective Larvae of Brugia malayi Induce Polarization of Host Macrophages that Helps in Immune Evasion. Frontiers in Immunology. 9, 194. DOI: 10.3389/fimmu.2018.00194.
10. Pathak, M., Sharma, P., Sharma, A., Verma, M., Srivastava, M., and Misra-Bhattacharya, S. (2016). Regulatory T-cell neutralization in mice during filariasis helps in parasite clearance by enhancing T helper type 17-mediated pro-inflammatory response. Immunology. 147, 190-203. DOI: 10.1111/imm.12550.
11. Ganga, L., Sharma, P., Tiwari, S., Satoeya, N., Jha, R., and Srivastava, M. Immunophenotypic and functional characterization of Eosinophil and migratory Dendritic cell subsets during filarial manifestation of Tropical Pulmonary Eosinophilia. ACS Infectious Diseases. DOI: 10.1021/acsinfecdis.3c00051.
12. Yadav, P.K., Chandrakar, P., Sharma, P., Vishwakarma, P., Parmar, N., Srivastava, M., and Kar, S. (2020). Reciprocal changes in CD11c(+)CD11b(+) and CD11c(+)CD8alpha(+) dendritic cell subsets determine protective or permissive immune response in murine experimental VL. Vaccine. 38, 355-365. DOI: 10.1016/j.vaccine.2019.10.004.
13. Borriello, F., Pietrasanta, C., Lai, J.C.Y., Walsh, L.M., Sharma, P., O'Driscoll, D.N., Ramirez, J., Brightman, S., Pugni, L., Mosca, F., et al. (2017). Identification and Characterization of Stimulator of Interferon Genes As a Robust Adjuvant Target for Early Life Immunization. Frontiers in Immunology. 8, 1772. DOI: 10.3389/fimmu.2017.01772.
14. Sharma, A., Sharma, P., Vishwakarma, A.L., and Srivastava, M. (2017). Functional Impairment of Murine Dendritic Cell Subsets following Infection with Infective Larval Stage 3 of Brugia malayi. Infection and Immunity. 85 (1): e00818-16. DOI: 10.1128/IAI.00818-16.

 

Chapter in book

Sharma, P., and Winau, F. (2022). CD1-Restricted T Cells. Paul's Fundamental Immunology; 8th Edition.

 

Patents filed (in USA)

1. Winau, F., and Sharma, P. Methods and compositions for enhanced antigen presentation in the tumor microenvironment. Application number: 63/350,734. CMCC 4140.
2. Winau, F., and Sharma, P. Lipid Gb3 as adjuvant for vaccination. WGS Ref. No.: C1233.70218US00. CMCC 3831.
3. Winau, F., and Sharma, P. The lipid Gb3 as a novel target for treatment of antibody-mediated autoimmunity. Application number: CMCC: 4218.

Opportunities

We are seeking highly motivated PhD candidates to join our research group. Our lab is also offering postdoctoral opportunities for highly motivated researchers to join our lab through national postdoctoral programs.


Back

Last updated On : 17 January 2025 03:57

Back to Top